Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.

Matsunaga K, Iijima H, Aota M, Oguchi Y, Fujii T, Yoshikumi C, Nomoto K.

Biomedical Research Laboratories, Kureha Chemical Industry, Co., Ltd., Tokyo, Japan.

Abstract

We investigated the effect of PSK, a protein-bound polysaccharide obtained from Coriolus versicolor of basidiomycetes, on antitumor immunity in tumor-bearing mice. PSK prolonged significantly the life span of C3H/He mice bearing syngeneic plasmacytoma X5563 in a schedule- and dose-dependent manner. PSK was most effective when administered at 100 mg/kg every other day ten times starting from the day after tumor inoculation. The administration of PSK enhanced significantly the cytostatic activity of peritoneal exudate plastic-adherent cells and the cytolytic activity of spleen cells after in vitro incubation with mitomycin C-treated tumor cells. In addition, PSK restored the cytokine-producing capacity of spleen cells suppressed in tumor-bearing mice after in vitro incubation with mitogen. Sera from tumor-bearing mice suppressed the activity of such effector cells as well as the interleukin 2-producing capacity of spleen cells, but sera from PSK-treated tumor-bearing mice prevented this suppression. These results suggest that PSK enhances antitumor immunity by reducing immunosuppressive activity of serum from tumor-bearing mice.

PMID: 1339233 [PubMed – indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/pubmed/1339233

One thought on “Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.”

  1. Hello

    Good Day, i have been exploring the internet right now
    trying to find a educational and informative and i found
    your blog and the infomation you share is very good i just
    wanted you to know that i really enjoyed you contents i’ll
    be back soon for more

    -Kathy

Comments are closed.